Scientific Advisory Board

Frank Porreca, PhD (Chairman)
Anthony W. Fox, MD, PhD
Bradley S. Galer, MD
Stephen Hanessian, PhD
James L. Henry, PhD
Jes Olesen, MD

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board

Anthony W. Fox, MD, PhD President EDB Group, former Vice president Drug Development and Regulatory Affairs, Cypros Pharmaceutucals

From 1994 to 1997 Dr Fox was Vice-President for Drug Development and Regulatory Affairs at Cypros Pharmaceuticals in Carlsbad, California, where he led two drugs from IND to Phase3. Prior positions include Director of Cardiovascular and Anaesthesia clinical research at Glaxo, where he led the US sumatriptan group and chaired the international remifentanil project (1990-1994). Group Leader with Procter and Gamble (phase 1 and 2 clinical trials and medical affairs). Dr Fox obtained three degrees from the University of London: BSc major in pharmacology (first class honours, 1977), his medical degree (1980) and a doctorate in pharmacology (1988). He is a Fellow of the Faculty and holds the Diploma in Pharmaceutical Medicine (Royal Colleges of Physicians, UK), Dr Fox is a Charter Member of the American Academy of Pharmaceutical Physicians. In addition, he is a Chartered Biologist and holds numerous other memberships or fellowships of academic societies. Dr Fox co-edited "Treating the Headache Patient" with Roger Cady, and was on the editorial team of the major textbook "Practice and Principles of Pharmaceutical Medicine" which is going into its second edition.